Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Conversations With Giants In Medicine

  • 80 Articles
  • 80 Posts
  • ← Previous
  • 1
  • 2
  • 3
  • …
  • 7
  • 8
  • Next →
Ending one conversation, starting another
Ushma S. Neill
Ushma S. Neill
Published April 1, 2025
Citation Information: J Clin Invest. 2025;135(7):e193004. https://doi.org/10.1172/JCI193004.
View: Text | PDF

Ending one conversation, starting another

  • Text
  • PDF
Abstract

Authors

Ushma S. Neill

×

A conversation with Zhijian (James) Chen
Ushma S. Neill
Ushma S. Neill
Published January 2, 2025
Citation Information: J Clin Invest. 2025;135(1):e189543. https://doi.org/10.1172/JCI189543.
View: Text | PDF

A conversation with Zhijian (James) Chen

  • Text
  • PDF
Abstract

Authors

Ushma S. Neill

×

Conversations with JCI editors in chief
Ushma S. Neill
Ushma S. Neill
Published October 15, 2024
Citation Information: J Clin Invest. 2024;134(20):e187017. https://doi.org/10.1172/JCI187017.
View: Text | PDF

Conversations with JCI editors in chief

  • Text
  • PDF
Abstract

Authors

Ushma S. Neill

×

A conversation with Stanley Prusiner
Ushma S. Neill
Ushma S. Neill
Published July 15, 2024
Citation Information: J Clin Invest. 2024;134(14):e183743. https://doi.org/10.1172/JCI183743.
View: Text | PDF

A conversation with Stanley Prusiner

  • Text
  • PDF
Abstract

Authors

Ushma S. Neill

×

A conversation with Elias Zerhouni
Ushma S. Neill
Ushma S. Neill
Published April 1, 2024
Citation Information: J Clin Invest. 2024;134(7):e180284. https://doi.org/10.1172/JCI180284.
View: Text | PDF

A conversation with Elias Zerhouni

  • Text
  • PDF
Abstract

Authors

Ushma S. Neill

×

A conversation with Olufunmilayo Olopade
Ushma S. Neill
Ushma S. Neill
Published January 16, 2024
Citation Information: J Clin Invest. 2024;134(2):e178495. https://doi.org/10.1172/JCI178495.
View: Text | PDF

A conversation with Olufunmilayo Olopade

  • Text
  • PDF
Abstract

Authors

Ushma S. Neill

×

A conversation with Peter Hotez
Ushma S. Neill
Ushma S. Neill
Published November 1, 2023
Citation Information: J Clin Invest. 2023;133(21):e176284. https://doi.org/10.1172/JCI176284.
View: Text | PDF

A conversation with Peter Hotez

  • Text
  • PDF
Abstract

Authors

Ushma S. Neill

×

A conversation with Elizabeth Jaffee
Ushma S. Neill
Ushma S. Neill
Published July 3, 2023
Citation Information: J Clin Invest. 2023;133(13):e172246. https://doi.org/10.1172/JCI172246.
View: Text | PDF

A conversation with Elizabeth Jaffee

  • Text
  • PDF
Abstract

Authors

Ushma S. Neill

×

A conversation with Katherine High
Ushma S. Neill
Ushma S. Neill
Published April 17, 2023
Citation Information: J Clin Invest. 2023;133(8):e170663. https://doi.org/10.1172/JCI170663.
View: Text | PDF

A conversation with Katherine High

  • Text
  • PDF
Abstract

Authors

Ushma S. Neill

×

A conversation with Jeffrey Whitsett
Ushma S. Neill
Ushma S. Neill
Published February 15, 2023
Citation Information: J Clin Invest. 2023;133(4):e168557. https://doi.org/10.1172/JCI168557.
View: Text | PDF

A conversation with Jeffrey Whitsett

  • Text
  • PDF
Abstract

Authors

Ushma S. Neill

×
  • ← Previous
  • 1
  • 2
  • 3
  • …
  • 7
  • 8
  • Next →
  • ← Previous
  • 1
  • 2
  • 3
  • …
  • 7
  • 8
  • Next →
JCI's Conversations with Giants in Medicine: Yuk Ming Dennis Lo
The winner of the 2022 Lasker~DeBakey Clinical Medical Research Award, Yuk Ming Dennis Lo is a physician-scientist at the Li Ka Shing Institute of Health Sciences of the Chinese University of Hong Kong.
Published December 15, 2022
Conversations with Giants in Medicine

JCI’s Conversations with Giants in Medicine: Vishva Dixit
On any given day, over 50 billion of the cells in your body will die. The question of how we live while our cells are continuously dying has captivated Dr. Vishva Dixit...
Published September 15, 2022
Conversations with Giants in Medicine

JCI’s Conversations with Giants in Medicine: Elizabeth Blackburn and Viviane Tabar
While great strides have been made with regard to gender equity in biomedical academia, there remains a stubborn imbalance in representation in senior leadership roles. The graduate students from the Gerstner Sloan Kettering Graduate School...
Published June 1, 2022
Conversations with Giants in Medicine

JCI’s Conversations with Giants in Medicine: Nora Volkow
In this episode, Ushma Neill interviews Nora Volkow, director of the National Institute on Drug Abuse (NIDA), about her work with trailblazing imaging studies of the brain’s frontal cortex and its dopamine-driven circuitry...
Published February 1, 2022
Conversations with Giants in Medicine

JCI’s Conversations with Giants in Medicine: Katalin Karikó
It has been estimated that in the first six months of 2021, mRNA-based vaccines against SARS-CoV-2 have saved 280,000 lives in the US alone and prevented well over a million hospitalizations. It is the scientific body of work of...
Published November 1, 2021
Conversations with Giants in Medicine

JCI’s Conversations with Giants in Medicine: Daniel Drucker
Dr. Dan Drucker, of the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, and the University of Toronto, is a diabetes treatment pioneer. Drucker’s early work explored the biosynthesis, secretion, and action of glucagon...
Published September 15, 2021
Conversations with Giants in Medicine

JCI’s Conversations with Giants in Medicine: Jesse Roth, Ron Kahn, and Jeff Flier
We shift our format this month to bring you three giants in medicine, Dr. Jesse Roth of the Feinstein Institutes for Medical Research, Dr. C. Ronald Kahn of the Joslin Diabetes Center at Harvard Medical School, and Dr. Jeffrey Flier...
Published June 15, 2021
Conversations with Giants in Medicine

Conversations with Giants in Medicine: Robert Lefkowitz
Robert Lefkowitz, physician-scientist from Duke University and the 2012 Nobel laureate in chemistry for his studies of GPCRs has recently written a memoir called A Funny Thing Happened on the Way to Stockholm...
Published April 1, 2021
Conversations with Giants in Medicine

JCI’s Conversations with Giants in Medicine: Griffin Rodgers
Beginning in the mid-1980s, Dr. Griffin Rodgers, Director of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health, led studies demonstrating the effectiveness of the drug hydroxyurea...
Published January 4, 2021
Conversations with Giants in Medicine

JCI's Conversations with Giants in Medicine: C. Ronald Kahn
C. Ronald (Ron) Kahn of the Joslin Diabetes Center at Harvard Medical School is a physician-scientist who illuminated much of what we appreciate about the insulin receptor and the means by which it signals.
Published October 1, 2020
Conversations with Giants in Medicine
  • ← Previous
  • 1
  • 2
  • 3
  • …
  • 7
  • 8
  • Next →
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts